Tuesday, February 13, 2018 7:22:45 AM
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Northwest Biotherapeutics, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
6673P600
(CUSIP Number)
December 31, 2017
(Date of Event Which Requires Filing of th is Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
a. ? Rule 13d-1(b)
b. ? Rule 13d-1(c)
c. ? Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 6
CUSIP No. 6673P600
1.
Names of Reporting Persons.
Mitchell P. Kopin
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ?
(b) ?
3.
SEC Use Only
4.
Citizenship or Place of Organization
United States of America
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
5.
Sole Voting Power
0
6.
Shared Voting Power
11,468,269
7.
Sole Dispositive Power
0
8.
Shared Dispositive Power
11,468,269
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
11,468,269 (see Item 4)
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ?
11.
Percent of Class Represented by Amount in Row (9)
3.6% (see Item 4)
12.
Type of Reporting Person (See Instructions)
IN; HC
Page 2 of 6
CUSIP No. 6673P600
1.
Names of Reporting Persons.
Daniel B. Asher
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ?
(b) ?
3.
SEC Use Only
4.
Citizenship or Place of Organization
United States of America
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
5.
Sole Voting Power
0
6.
Shared Voting Power
11,468,269
7.
Sole Dispositive Power
0
8.
Shared Dispositive Power
11,468,269
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
11,468,269 (see Item 4)
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ?
11.
Percent of Class Represented by Amount in Row (9)
3.6% (see Item 4)
12.
Type of Reporting Person (See Instructions)
IN; HC
Page 3 of 6
CUSIP No. 6673P600
1.
Names of Reporting Persons.
Intracoastal Capital LLC
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ?
(b) ?
3.
SEC Use Only
4.
Citizenship or Place of Organization
United States of America
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
5.
Sole Voting Power
0
6.
Shared Voting Power
11,468,269
7.
Sole Dispositive Power
0
8.
Shared Dispositive Power
11,468,269
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
11,468,269 (see Item 4)
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ?
11.
Percent of Class Represented by Amount in Row (9)
3.6% (see Item 4)
12.
Type of Reporting Person (See Instructions)
OO
Page 4 of 6
This Amendment No. 1 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the Securities and Exchange Commission (the “ SEC ”) on March 24, 2017 (the “ Schedule 13G ”).
Except as set forth below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13G.
Item 4. Ownership.
(a) and (b):
As of the close of business on December 31, 2017, each of the Reporting Persons may have been deemed to have beneficial ownership of 11,468,269 shares of Common Stock, w hich consisted of (i) 4,762,500 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (“ Intracoastal Warrant 1 ”) , (ii) 1,250,000 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal (“ Intracoastal Warrant 2 ”), (iii) 3,605,769 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal (“ Intracoastal Warrant 3 ”), and (iv) 1,850,000 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal (“ Intracoastal Warrant 4 ”), and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately 3.6% of the Common Stock, based on (1) 309,675,000 shares of Common Stock outstanding as of September 30, 2017 as reported by the Issuer , plus (2) 4,762,500 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 , (3) 1,250,000 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, (4) 3,605,769 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 and (5) 1,850,000 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4.
(c)
Number of shares as to which each Reporting Person has:
(1) Sole power to vote or to direct the vote: 0 .
(2) Shared power to vote or to direct the vote: 11,468,269 .
(3) Sole power to dispose or to direct the disposition of 0 .
(4) Shared power to dispose or to direct the disposition of 11,468,269 .
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ .
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
Page 5 of 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 13, 2018
/s/ Mitchell P. Kopin
Mitchell P. Kopin
/s/ Daniel B. Asher
Daniel B. Asher
Intracoastal Capital LLC
By: /s/ Mitchell P. Kopin
Mitchell P. Kopin, Manager
Page 6 of 6
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM